{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:52:36Z","timestamp":1791237156402,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.autrev.2006.10.005","type":"journal-article","created":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T09:24:38Z","timestamp":1165051478000},"page":"537-542","source":"Crossref","is-referenced-by-count":146,"title":["Hyperprolactinemia and autoimmune diseases"],"prefix":"10.1016","volume":"6","author":[{"given":"Hedi","family":"Orbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2006.10.005_bib1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1567-5769(01)00045-5","article-title":"Estrogen, prolactin, and autoimmunity: actions and interactions","volume":"1","author":"McMurray","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2006.10.005_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1999.tb07629.x","article-title":"Prolactin and neuroimmunomodulation: in vitro and in vivo observations","volume":"876","author":"Chikanza","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2006.10.005_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2005.05.014","article-title":"Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes","volume":"101","author":"Peeva","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.autrev.2006.10.005_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI200316530","article-title":"Prolactin modulates the naive B cell repertoire","volume":"111","author":"Peeva","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2006.10.005_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1677\/joe.0.1780265","article-title":"Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells","volume":"178","author":"Kochendoerfer","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.autrev.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/clin.1993.1026","article-title":"Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro","volume":"66","author":"Athreya","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1191\/096120301717164967","article-title":"Effect of prolactin on antigen presenting function of mononocyte derived dendritic cells","volume":"10","author":"Matera","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0165-5728(93)90282-4","article-title":"Differential effects of prolactin upon activation and differentiation of human B lymphocytes","volume":"47","author":"Lahat","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2006.10.005_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1191\/096120398678920316","article-title":"Anti-endothelial cell antibodies in the sera of hyperprolactinemic women","volume":"7","author":"Krause","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2006.10.005_bib10","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1568-9972(02)00081-2","article-title":"Prolactin and autoimmunity","volume":"1","author":"Vera-Lastra","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1297-319X(03)00151-9","article-title":"Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?","volume":"71","author":"El Miedany","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2006.10.005_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.autrev.2006.10.005_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/art.1780400804","article-title":"Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus","volume":"40","author":"Brennan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.10.005_bib14","first-page":"629","article-title":"No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus","volume":"23","author":"Buskila","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/kei115","article-title":"Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity","volume":"45","author":"Leanos-Miranda","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1172\/JCI10420","article-title":"Bromocriptine restores tolerance in estrogen-treated mice","volume":"106","author":"Peeva","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2006.10.005_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.1999.tb07634.x","article-title":"Basal and after-stimuli test for prolactinemia in systemic lupus erythematosus","volume":"876","author":"Zoli","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2006.10.005_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1191\/096120301717164994","article-title":"Prolactin in human systemic lupus erythematosus","volume":"10","author":"Jara","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2006.10.005_bib19","first-page":"1546","article-title":"Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity","volume":"28","author":"Leanos-Miranda","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s10067-005-0117-x","article-title":"Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?","volume":"25","author":"Li","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2006.10.005_bib21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/cimm.1995.1058","article-title":"Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells","volume":"162","author":"Blank","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.autrev.2006.10.005_bib22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1191\/096120301717165010","article-title":"Bromocriptine treatment of systemic lupus erythematosus","volume":"10","author":"Walker","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2006.10.005_bib23","first-page":"2084","article-title":"Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus","volume":"22","author":"McMurray","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1191\/096120398678920334","article-title":"Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study","volume":"7","author":"Alvarez-Nemegyei","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2006.10.005_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-4530(94)90003-5","article-title":"Therapeutic effect of the D2-dopamine agonist bromocriptine on acute and relapsing experimental allergic encephalomyelitis","volume":"19","author":"Dijkstra","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.autrev.2006.10.005_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(91)90094-N","article-title":"Hyperprolactinemia in multiple sclerosis","volume":"102","author":"Kira","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2006.10.005_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00002826-199410000-00011","article-title":"Bromocriptine therapy in multiple sclerosis: an open label pilot study","volume":"17","author":"Bissay","year":"1994","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.autrev.2006.10.005_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2377-6-19","article-title":"Monthly i.v. methylprednisolone in relapsing-remitting MS-Reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations","volume":"23","author":"Then Bergh","year":"2006","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2006.10.005_bib29","first-page":"177","article-title":"Serum prolactin level in patients with multiple sclerosis: a case control study","volume":"12","author":"Harirchian","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2006.10.005_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0950-3579(96)80018-5","article-title":"The neuroendocrine immunology of rheumatoid arthritis","volume":"10","author":"Chikanza","year":"1996","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s100670200076","article-title":"ACTH, cortisol and prolactin in active rheumatoid arthritis","volume":"21","author":"Zoli","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib32","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/keh307","article-title":"Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact?","volume":"43","author":"Ram","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2006.10.005_bib33","first-page":"28","article-title":"Hormones, pregnancy, and rheumatoid arthritis","volume":"5","author":"Olsen","year":"2002","journal-title":"J Gend Specif Med"},{"key":"10.1016\/j.autrev.2006.10.005_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sarh.2001.25482","article-title":"Bromocriptine in rheumatic and autoimmune diseases","volume":"31","author":"McMurray","year":"2001","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2006.10.005_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1753-4887.2001.tb05511.x","article-title":"Breastfeeding-related onset, flare, and relapse of rheumatoid arthritis","volume":"59","author":"Hampl","year":"2001","journal-title":"Nutr Rev"},{"key":"10.1016\/j.autrev.2006.10.005_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02229718","article-title":"High serum level of prolactin in patients with systemic sclerosis","volume":"15","author":"Kucharz","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biopha.2006.02.007","article-title":"Prolactin synthesis by lymphocytes from patients with systemic sclerosis","volume":"60","author":"Czuwara-Ladykowska","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2006.10.005_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/ard.53.6.425-a","article-title":"Hyperprolactinaemia in primary Sjogren's syndrome","volume":"53","author":"Gutierrez","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2006.10.005_bib39","first-page":"1291","article-title":"The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome","volume":"26","author":"Haga","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2006.10.005_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1507\/endocrj.44.89","article-title":"Incidence of hyperprolactinemia in patients with Hashimoto's thyroiditis","volume":"44","author":"Notsu","year":"1997","journal-title":"Endocr J"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206002096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997206002096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T22:55:39Z","timestamp":1547160939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997206002096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1568997206002096"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2006.10.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}